Cas 1174683-46-5,N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-d3-methyl-piperidin-4-yl)methoxy)quinazolin-4-amine

1174683-46-5

Post Buying Request

Basic information

Product Name: N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-d3-methyl-piperidin-4-yl)methoxy)quinazolin-4-amine
Synonyms: N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-d3-methyl-piperidin-4-yl)methoxy)quinazolin-4-amine
CAS NO:1174683-46-5
Molecular Formula:
Molecular Weight: 478.337
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-d3-methyl-piperidin-4-yl)methoxy)quinazolin-4-amine(CAS DataBase Reference)
NIST Chemistry Reference: N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-d3-methyl-piperidin-4-yl)methoxy)quinazolin-4-amine(1174683-46-5)
EPA Substance Registry System: N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-d3-methyl-piperidin-4-yl)methoxy)quinazolin-4-amine(1174683-46-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1174683-46-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1174683-46-5 Suppliers

Recommended suppliers

1174683-46-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1174683-46-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,4,6,8 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1174683-46:
(9*1)+(8*1)+(7*7)+(6*4)+(5*6)+(4*8)+(3*3)+(2*4)+(1*6)=175
175 % 10 = 5
So 1174683-46-5 is a valid CAS Registry Number.

1174683-46-5Upstream product

1174683-46-5Downstream Products

1174683-46-5Relevant academic research and scientific papers

SUBSTITUTED QUINAZOLINE INHIBITORS OF GROWTH FACTOR RECEPTOR TYROSINE KINASES

-

Page/Page column 24-25, (2010/04/23)

The present invention relates to new substituted quinazoline inhibitors of vascular endothelial growth factor receptor tyrosine kinase, epidermal growth factor receptor tyrosine kinase, and/or REarranged during Transfection tyrosine kinase, pharmaceutical compositions thereof, and methods of use thereof.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1174683-46-5